Opus Genetics, Inc.: accumulated depreciation on property, plant and equipment

What this measure means

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Exact concept: us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2011-12-31 to 2023-12-31. The SEC response was captured on 2026-09-20.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Related financial histories

• Opus Genetics, Inc.: total assets
• Opus Genetics, Inc.: total liabilities
• Opus Genetics, Inc.: stockholders equity
• Opus Genetics, Inc.: cash and cash equivalents
• Opus Genetics, Inc.: net income or loss
• Opus Genetics, Inc.: operating cash flow
• Opus Genetics, Inc.: revenue
• Opus Genetics, Inc.: contract revenue excluding tax
• Opus Genetics, Inc.: financing cash flow
• Opus Genetics, Inc.: investing cash flow
• Opus Genetics, Inc.: retained earnings or deficit
• Opus Genetics, Inc.: basic weighted-average shares
• Opus Genetics, Inc.: diluted weighted-average shares
• Opus Genetics, Inc.: basic earnings per share
• Opus Genetics, Inc.: diluted earnings per share
• Opus Genetics, Inc.: income tax expense or benefit
• Opus Genetics, Inc.: net property, plant and equipment
• Opus Genetics, Inc.: share-based compensation expense
• Opus Genetics, Inc.: operating income or loss
• Opus Genetics, Inc.: current assets
• Opus Genetics, Inc.: interest expense
• Opus Genetics, Inc.: current liabilities
• Opus Genetics, Inc.: current accounts payable
• Opus Genetics, Inc.: net current accounts receivable
• Opus Genetics, Inc.: operating expenses
• Opus Genetics, Inc.: research and development expense
• Opus Genetics, Inc.: common shares outstanding
• Opus Genetics, Inc.: cash including restricted cash
• Opus Genetics, Inc.: additional paid-in capital
• Opus Genetics, Inc.: accumulated other comprehensive income or loss
• Opus Genetics, Inc.: gross property, plant and equipment
• Opus Genetics, Inc.: accrued current liabilities
• Opus Genetics, Inc.: prepaid expenses and other current assets
• Opus Genetics, Inc.: net deferred tax assets
• Opus Genetics, Inc.: pre-tax income or loss from continuing operations
• Opus Genetics, Inc.: comprehensive income or loss
• Opus Genetics, Inc.: general and administrative expense
• Opus Genetics, Inc.: depreciation expense
• Opus Genetics, Inc.: other nonoperating income or expense
• Opus Genetics, Inc.: nonoperating income or expense
• Opus Genetics, Inc.: current income tax expense or benefit
• Opus Genetics, Inc.: interest paid, net
• Opus Genetics, Inc.: income taxes paid, net
• Opus Genetics, Inc.: proceeds from issuing common stock
• Opus Genetics, Inc.: change in accounts receivable
• Opus Genetics, Inc.: change in accounts payable

Inspect the source

Entity

Opus Genetics, Inc. / CIK 0001228627

Captured

2026-09-20T07:46:24.028Z

SEC response SHA-256

59b3f548361fa5c66fb8bd927bac9bc7dc8822bcce158860c7c4d77974af0a92

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001228627.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))